Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF LEGAL OFFICER, SECRETARY | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 117,616 |
Ending reported balance
After 2026-09-02 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 5,350 · Balance 115,611 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 9,152 · Balance 124,763 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 426 · Balance 125,189 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 7,573 · Balance 117,616 F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,700 |
Reported balance
After 2026-09-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-01 · Exercise / conversion · Disposed 5,350 · Balance 10,700 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 54,918 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 9,152 · Balance 54,918 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,553 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 426 · Balance 2,553 F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4: On March 19, 2024, the reporting person was granted 64,200 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F5: On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6: On March 1, 2026, the reporting person earned 5,107 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2025 Filed Mar 21, 2025 20:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 21,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000034 · wk-form4_1742588409.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,800 Underlying: Common Stock · 21,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F3 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 20:20 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 21,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000034 · wk-form4_1742588409.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 3,935 | $9.68 | $38,106.54 |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,919 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 109,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,832 Underlying: Common Stock · 109,832 shares Expires not disclosed F7 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock F8 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F8 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,025 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,672 Underlying: Common Stock · 4,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:06 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000016 · wk-form4_1741122364.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,004 | $11.93 | $47,755.71 |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,050 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,090 Underlying: Common Stock · 4,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,881 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,530 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,418 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049798 · wk-form4_1733264934.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 03, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,817 | $7.16 | $20,180.99 |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,250 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,508 Underlying: Common Stock · 4,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,762 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,035 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 20:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000191 · wk-form4_1725480748.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,015 | $11.16 | $44,795.36 |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,264 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 4,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · derivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,925 Underlying: Common Stock · 4,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · derivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,643 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · derivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,540 Underlying: Common Stock · 1,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:05 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,505 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,981 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 64,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000066 · wk-form4_1710965371.xml · derivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,200 Underlying: Common Stock · 64,200 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 15,653 | $14.52 | $227,218.95 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 7 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,476 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 14 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,912 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F12 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F12 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 17,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 13 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,342 Underlying: Common Stock · 17,671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F11 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F11 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 12 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,524 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F10 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 1,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 11 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 730 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 10 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 730 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On March 2, 2023, the reporting person earned 1,457 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. F8 · derivative.expiration_date: On March 2, 2023, the reporting person earned 1,457 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 6,022 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 9 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,045 Underlying: Common Stock · 6,022 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F7 · derivative.expiration_date: On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 18,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · derivative · entry 8 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,067 Underlying: Common Stock · 18,067 shares Expires not disclosed F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F5 · shares: Performance award amount determined based on metrics in respect of the issuer's 2023 financial results. F6 · derivative.exercise_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. F6 · derivative.expiration_date: The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 6 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 17,671 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 5 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 4 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-24-000045 · wk-form4_1709672973.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 04, 2023 Filed Dec 5, 2023 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 965 | $18.90 | $18,240.43 |
DisclosureSEC source: 0001477449-23-000104 · wk-form4_1701810418.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,467 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000104 · wk-form4_1701810418.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,405 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-23-000104 · wk-form4_1701810418.xml · nonDerivative · entry 1 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 20:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 961 | $22.89 | $22,001.13 |
DisclosureSEC source: 0001477449-23-000044 · wk-form4_1694031459.xml · nonDerivative · entry 2 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,551 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 20:17 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-23-000044 · wk-form4_1694031459.xml · derivative · entry 3 Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,286 Underlying: Common Stock · 1,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.